报价延迟最少15分钟:2026/02/12 08:07 EST
盘前时段
|
||||
|
648.02 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
648.73
|
|
|
| 价值评估 |
|
盈利(现时/预测)
12.61/15.75
|
|
企业价值
52.17B
|
| 资产负债 |
|
每股账面净值
20.10
|
| 现金流量 |
|
现金流量率
0.02
|
| 损益表 |
|
收益
3.90B
|
|
每股收益
44.93
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ inthe office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States. |
